Alexion Pharmaceuticals, Inc.
ALXNDelisted Jul 21, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000899866
Alexion Pharmaceuticals, Inc. was delisted on Jul 21, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 711 institutions reported holding it in 13F filings for Q2 2021, worth $39.1B in total; superinvestors Soros Fund Management and Maverick Capital held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Alexion Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Alexion Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Coughlin Christopher J | Director | 0 | Jul 23, 2021 | 0 |
| Friedman Paul A | Director | 0 | Jul 23, 2021 | 0 |
| Reinsdorf Judith A | Director | 0 | Jul 23, 2021 | 0 |
| Dunsire Deborah | Director | 0 | Jul 23, 2021 | 0 |
| Nader Francois | Director | 0 | Jul 23, 2021 | 0 |
| Mollen John T | Director | 0 | Jul 23, 2021 | 0 |
| Chiniara Ellen | EVP & Chief Legal Officer | 0 | Jul 23, 2021 | 0 |
| Rummelt Andreas | Director | 0 | Jul 23, 2021 | 0 |
| Hantson Ludwig | CEO | 9,098 | Jul 23, 2021 | 0 |
| Goff Brian | EVP & Chief Commercial Officer | 0 | Jul 23, 2021 | 0 |
| Brennan David R | Director | 0 | Jul 23, 2021 | 0 |
| Orloff John J | EVP, Research & Development | 0 | Jul 23, 2021 | 0 |
| Franchini Indrani Lall | EVP, Chief Compliance Officer | 0 | Jul 23, 2021 | 0 |
| Sarin Aradhana | EVP, CFO | 0 | Jul 23, 2021 | 0 |
| Bazarko Daniel | SVP, Controller, CAO | 0 | Jul 23, 2021 | 0 |
| Carino Tanisha | EVP & CCAO | 0 | Jul 23, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.